Perspectives of biotechnological production of l-ribose and its purification

被引:30
作者
Hu, Chao [1 ]
Li, Liangzhi [1 ]
Zheng, Yayue [1 ]
Rui, Lilian [1 ]
Hu, Cuiying [1 ]
机构
[1] Suzhou Univ Sci & Technol, Sch Chem & Bioengn, Suzhou 215011, Peoples R China
基金
中国博士后科学基金;
关键词
L-Ribose; Biotransformation; Ribitol; L-Arabinose; Escherichia coli; Purification; HEPATITIS-B-VIRUS; MANNOSE-6-PHOSPHATE ISOMERASE; L-ARABINOSE; SEPARATION; SUBSTRATE; MEMBRANES; MUTANTS; RIBITOL; ANALOG;
D O I
10.1007/s00253-011-3552-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
l-Ribose is a non-natural and expensive sugar that can be used as an important intermediate for the synthesis of l-nucleoside analogues, which are used as antiviral drugs. In contrast to chemical production, biotechnological methods can produce l-ribose from biomass under environmentally friendly conditions. In this mini-review, various strategies for synthesizing l-ribose by applying microorganisms and their enzymes are discussed, including microbial biotransformation and biocatalysis by engineering bacteria. Furthermore, subsequent isolation-and-purification techniques, as an integral step in the whole process, are accordingly described, containing the especial introduction of a promising strategy of l-ribose separation. Particularly, further researches and outlook for the improvement of l-ribose preparation was solely stressed. Compared with each method, this mini-review provides a panorama of respective advantages and disadvantages existing in them.
引用
收藏
页码:449 / 455
页数:7
相关论文
共 47 条
  • [21] Leisola M, 2001, BIOTECHNOL BIOENG, V72, P501, DOI 10.1002/1097-0290(20010220)72:4<501::AID-BIT1013>3.0.CO
  • [22] 2-J
  • [23] LI LZ, 2008, Patent No. 101260414
  • [24] LI LZ, 2008, Patent No. 101294176
  • [25] Unique metabolism of a novel antiviral L-nucleoside analog, 2′-fluoro-5-methyl-β-L-arabinofuranosyluracil:: a substrate for both thymidine kinase and deoxycytidine kinase
    Liu, SH
    Grove, KL
    Cheng, YC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) : 833 - 839
  • [26] Crystal structure of Escherichia coli L-arabinose isomerase (ECAI), the putative target of biological tagatose production
    Manjasetty, Babu A.
    Chance, Mark R.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2006, 360 (02) : 297 - 309
  • [27] L-Nucleoside enantiomers as antivirals drugs:: A mini-review
    Mathe, Christophe
    Gosselin, Gilles
    [J]. ANTIVIRAL RESEARCH, 2006, 71 (2-3) : 276 - 281
  • [28] Controlling the nanofiltration properties of multilayer polyelectrolyte membranes through variation of film composition
    Miller, MD
    Bruening, ML
    [J]. LANGMUIR, 2004, 20 (26) : 11545 - 11551
  • [29] A convenient synthesis of L-ribose from D-fructose
    Perali, Ramu Sridhar
    Mandava, Suresh
    Bandi, Ramakrishna
    [J]. TETRAHEDRON, 2011, 67 (22) : 4031 - 4035
  • [30] Pyun YR, 2006, KR Patent, Patent No. 2006110647